Woman is holding the textile home made face mask used for protection against viruses while walking in the nature. Symbol for protest against regulations or freedom after end of pandemic.
According to results from lab studies, an antibody-based COVID-19 therapy developed by GSK and Vir Biotechnology preserves neutralising activity against the developing BA.2 type of the Omicron coronavirus variant.
The business stated it would reveal preprint data in the coming week, followed by live viral data.
According to the business, the 500 mg dose of sotrovimab is sufficient to maintain action against the BA.2 variation, which is in line with all other variants of concern and interest, based on pseudovirus and substantial pharmacokinetic data.
Sotrovimab is one of the few COVID-19 therapies that has been demonstrated to act against the fast-spreading Omicron form, which has sparked interest. In 2021, it was one of GSK’s best-selling products.
Rice water, rich in inositol, antioxidants, vitamins, and minerals, protects hair from sunlight damage and…
Natural Remedies for Bloating: 8 Herbs and Supplements That Work Wonders for Your Gut Health…
Benefits of Oil Pulling: Stops Bad Breath, Keeps Gums Healthy, But Can't Replace Brushing Oil…
Spicy food – whether it’s a dash of chili in your curry, a spoonful of…
How To Identify Adulterated Wheat Flour? Try These 4 Easy Tests Wheat flour is a…
Reasons That Will Make You Eat Jaggery After Every Meal (Potential Health Benefits Inside) Jaggery,…